Journal
PHARMACOLOGY
Volume 92, Issue 5-6, Pages 286-302Publisher
KARGER
DOI: 10.1159/000355835
Keywords
Non-neuronal cholinergic system; Acetylcholine; Nicotinic receptors; Muscarinic receptors; Choline acetyltransferase; Vesicular acetylcholine transporter; Organic cation transporter; Acetylcholinesterase
Categories
Funding
- HMWK
- DFG [SFB/TR 79, B7]
Ask authors/readers for more resources
Acetylcholine (ACh) is not only a neurotransmitter but is an ancient molecule that can be released by and act on non-neuronal cells. In these cells the system of ACh-synthesizing enzymes, transporters, receptors and degrading enzymes is termed the non-neuronal cholinergic system (NNCS). There is increasing evidence that the NNCS is dysregulated in various diseases and can have an influence on their pathology. However, for many organ systems not much is known about the expression and function of the NNCS. Thus, this review focusses on the role of the NNCS in different organ systems in health and disease. Dysregulation of ACh synthesis and release, mutations or polymorphisms in genes encoding NNCS components, and auto-antibodies against NNCS components are common factors influencing disease progression. Pharmacological agents targeting the NNCS are already successfully in clinical use for some disorders, indicating that interfering with this system is very promising and more research is needed to elucidate the role of the NNCS in different tissues and pathological states. (C) 2013 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available